Chlorcyclizine (hydrochloride)

目录号: GC13465纯度: >99.50%同义词: 盐酸氯环利嗪;盐酸氯环力嗪
A histamine H1 antagonist

Chlorcyclizine (hydrochloride)
Cas No.: 14362-31-3
规格价格库存数量操作
100mg¥540.00现货
1
200mg¥810.00现货
1
500mg¥1,710.00现货
1
10mM (in 1mL DMSO)¥594.00现货
1

文献被引

本产品暂无引用记录;以下为 GlpBio 产品在 Nature / Cell / Science 等顶刊的客户引用样例
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

产品描述 Description

Chlorcyclizine is a phenylpiperazine antagonist for histamine H1 receptor [1].

The histamine has been involved in modulating many physiological functions of the hypothalamus, such as arousal state, feeding, locomotor activity, and drinking. Histamine has been involved in circadian rhythm of locomotor activity and exploratory behavior through H1R [1].

In vitro: The Ki value of chlorcyclizine for histamine H1 receptor was 9 nM [1]. Chlorcyclizin was effective against hepatitis C virus (HCV) with an EC50 of 44 nM, preventing viral entry into host cells [2].

In vivo: In chimeric mice xenografted with primary human hepatocytes, chlorcyclizine (10-50 mg/kg) significantly inhibited infection of HCV genotypes 1b and 2a [2]. Chlorcyclizine induced a resistance to sodium pentobarbital anesthesia. Intraperitoneal injection of chlorcyclizine showed a sedative effect in small doses, but a convulsive effect in large doses. Intraperitoneal injections of the drug did not affect the recovery time from pentobarbital anesthesia [3]. In rats, pretreatment with chlorcyclizine for several days shortened the duration of action of a subsequent dose of hexobarbital, pentobarbital or zoxazolamine, and accelerated in vivo metabolism of hexobarbital [4]. The administration of chlorcyclizine (50 g/kg) to rats by stomach tube daily for 1 week resulted in significant increases in liver weight, microsomal protein concentration and the activity of the NADPH-dependent hepatic microsomal ethanol-oxidizing system (MEOS) [5].

References:
[1] Tran V T, Chang R S, Snyder S H.  Histamine H1 receptors identified in mammalian brain membranes with [3H] mepyramine[J]. Proceedings of the National Academy of Sciences, 1978, 75(12): 6290-6294.
[2] He, S. ,Xiao, J.,Dulcey, A.E., et al. Discovery, optimization, and characterization of novel chlorcyclizine derivatives for the treatment of hepatitis C virus infection. Journal of Medicinal Chemistry 59(3), 841-853 (2016).
[3] Thompson I D, Dolowy W C, Cole W H.  Development of a resistance to sodium pentobarbital in rats fed on a diet containing chlorcyclizine hydrochloride[J]. Journal of Pharmacology and Experimental Therapeutics, 1959, 127(2): 164-166.
[4] Conney A H, Burns J J, Michaelson I A.  Stimulatory effect of chlorcyclizine on barbiturate metabolism[J]. Journal of Pharmacology and Experimental Therapeutics, 1961, 132(2): 202-206.
[5] Khanna J M, Kalant H, Lin G.  Significance in vivo of the increase in micro-somal ethanol-oxidizing system after chronic administration of ethanol, pheno-barbital and chlorcyclizine[J]. Biochemical pharmacology, 1972, 21(16): 2215-2226.

实验参考方法 Experimental Reference Method

Animal experiment:

Rats[1]Timed-mated CRL:CD [SD] female rats between 9 and 13 weeks of age at initiation of dosing and weighing between 245 and 363 g are used. Rats are administered a single daily oral gavage dose of 30, 60, or 90 mg/kg Chlorcyclizine (n=8/group) during the sensitive period for palate development, GDs 11 to 14. These doses are selected such that 30 mg/kg is a likely no-effect dose and higher doses of 60 and/or 90 mg/kg will induce a moderate or high incidence of fetal cleft palate. Given that CRL:CDs [SD] rats have an extremely low incidence of spontaneous cleft palate in the testing laboratory, as well as to avoid unnecessary use of animals, a methylcellulose control group is omitted[1].

References:

[1]. Enright BP, et al. Effects of the histamine H1 antagonist Chlorcyclizine on rat fetal palate development. Birth Defects Res B Dev Reprod Toxicol. 2010 Dec;89(6):474-84.

产品文档 Product Documents

Purity:>99.50%

化学性质Chemical Properties

CAS 号
14362-31-3
同义词
盐酸氯环利嗪;盐酸氯环力嗪
化学名
1-[(4-chlorophenyl)phenylmethyl]-4-methyl-piperazine, monohydrochloride
SMILES
CN1CCN(C(C2=CC=C(Cl)C=C2)C3=CC=CC=C3)CC1.Cl
分子式
C18H21ClN2 • HCl
分子量
337.3 g/mol
溶解性
≥ 11mg/mL in DMSO with gentle warming
保存条件
Store at -20°C
General tips
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至 37°C,然后在超声波浴中震荡一段时间。
Shipping Condition
评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备 RT,或根据请求配备蓝冰。

计算工具摩尔浓度 / 稀释 / 分子量 / 单位换算 / 体内配方 / 溶解度

g/mol